Marion Berdal

Marion Berdal is a Researcher in the Supporting clinical sciences department at an institution in Brussels, Belgium. Her work focuses on molecular imaging and targeted therapies for oncological applications, particularly in the context of tumour models and fibroblast activation protein (FAP) targeting.

Research Interests: Berdal’s research spans molecular imaging, nuclear medicine, and single-domain antibody development for cancer therapy. She specializes in leveraging radionuclide-based approaches to target FAP, a key player in tumour microenvironment dynamics.

Publications: Her recent work includes studies on radiotheranostic single-domain antibodies and their efficacy in aggressive preclinical tumour models. These contributions highlight advancements in molecular imaging and dual-targeted radionuclide therapy.